Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess

Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess

Saved in:

Bibliographic Details
Main Authors:	Francis de Zegher, Lourdes Ibáñez
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Series:	Acta Obstetricia et Gynecologica Scandinavica
Online Access:	https://doi.org/10.1111/aogs.14802
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
by: Marta Díaz, et al.
Published: (2018-01-01)

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome
by: Zhao Ting, et al.
Published: (2024-12-01)

Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome
by: Sukirti Misra, et al.
Published: (2025-05-01)

Follicular development and endometrial receptivity of different androgen phenotypes in women with polycystic ovary syndrome
by: Xinling Wen, et al.
Published: (2024-12-01)

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
by: Rosa Lauretta, et al.
Published: (2016-01-01)

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
by: E. M. Bogatyreva, et al.
Published: (2018-07-01)

The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
by: Xueming Huang, et al.
Published: (2025-06-01)

Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome
by: Yishu Wang, et al.
Published: (2025-08-01)

Correction of meta-analysis after retraction of article on the effects of anti-androgens in polycystic ovary syndrome
by: Simon Alesi, et al.
Published: (2025-01-01)

The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS).
by: Mick Rae, et al.
Published: (2013-01-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Ayurvedic Management of Insulin Resistance-related Conditions in Polycystic Ovary Syndrome
by: Anshul Chauhan, et al.
Published: (2025-01-01)

Fecal propionate is a signature of insulin resistance in polycystic ovary syndrome
by: Sitong Dong, et al.
Published: (2025-01-01)

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
by: Balachandran Kumarendran, et al.
Published: (2018-03-01)

Exploring the Mechanisms of How Excess Androgens Adversely Impact Lipid Metabolism in Women with Polycystic Ovarian Syndrome
by: M. Wang, et al.
Published: (2025-06-01)

Protective effect of Yunkang oral liquid via regulating androgen receptor in polycystic ovary syndrome rats
by: Xiang Zheng, et al.
Published: (2024-12-01)

Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes
by: Emídio Vale-Fernandes, et al.
Published: (2025-07-01)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
by: Arturo Hernández-Yero, et al.
Published: (2012-01-01)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
by: Shou-Kui Xiang, et al.
Published: (2012-01-01)

Estimation the activity of Copeptin, insulin, and C-peptide from patients with polycystic ovary syndrome
by: Entedhar R. Sarhat, et al.
Published: (2018-08-01)

A nomogram to predict the risk of insulin resistance in Chinese women with polycystic ovary syndrome
by: Benjie Guo, et al.
Published: (2024-11-01)

Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome
by: Jie Yang, et al.
Published: (2024-12-01)

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
by: Tommy Kyaw Tun, et al.
Published: (2016-01-01)

Intelectin-1 and Endocrinological Parameters in Women with Polycystic Ovary Syndrome: Effect of Insulin Resistance
by: Adnan Jassim Mohammed Al-Fartosy, et al.
Published: (2020-01-01)

Phosphorylation-stabilized CRTC1 cooperates with CBP and androgen receptor to transactivate AMH expression and drive polycystic ovary syndrome
by: Yunmei Ke, et al.
Published: (2025-06-01)

Insulin Resistance, Adiponectin, and Dyslipidemia as Key Determinants of Metabolic and Reproductive Dysregulation in Polycystic Ovary Syndrome
by: Krarr Haider Haddawi, et al.
Published: (2025-04-01)

Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome
by: Khulood Hussein, et al.
Published: (2023-06-01)

The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome
by: Mengyi Zhu, et al.
Published: (2024-12-01)

Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
by: Yuqin Zhang, et al.
Published: (2025-07-01)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
by: Cong Hu, et al.
Published: (2020-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

From the history of polycystic ovary syndrome
by: D. A. Kiryushkina
Published: (2019-09-01)

Polycystic Ovary Syndrome - treatment update
by: Marta Szymura, et al.
Published: (2025-07-01)

Review on: Women with Polycystic Ovary Syndrome
by: Neelam Gusain, et al.
Published: (2025-05-01)

Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
by: Danlan Pu, et al.
Published: (2019-01-01)

Frequency of Polycystic Ovary Syndrome and “Being at Risk for Polycystic Ovary Syndrome” in Obese Adolescent Girls in Light of Current Definitions
by: Özlem Yüksel, et al.
Published: (2025-09-01)

Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome
by: Sahar Mazloomi, et al.
Published: (2021-01-01)

Influence of Whey Protein Supplementation on Insulin Sensitivity and Inflammatory Response in Women With and Without Polycystic Ovary Syndrome
by: Monique J LeMieux, et al.
Published: (2025-05-01)

Effect of impaired sensitivity to thyroid hormones on the risk of insulin resistance and dyslipidemia in polycystic ovary syndrome patients
by: Yang You, et al.
Published: (2025-12-01)

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
by: Ruihan Wang, et al.
Published: (2025-01-01)